FIGS (FIGS) 주식 개요
는 자회사인 FIGS Canada, Inc.와 함께 미국 및 전 세계에서 소비자 직접 판매 헬스케어 의류 및 라이프스타일 회사로 운영되고 있습니다. 자세히 보기
FIGS Community Fair Values
Create NarrativeSee what 15 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Top Community Narratives
JU
Community Contributor
Figs valuation
REVIEW Sales are growing and the business is reinvesting in its operations. Has decreased its current liabilities to 14% of total assets.
View narrativeUS$7.21
FV
113.6% 고평가 내재 할인율9.00%
Revenue growth p.a.
1k
users have viewed this narrative8users have liked this narrative
6users have commented on this narrative
19users have followed this narrative
FIGS, Inc. 경쟁사
가격 이력 및 성과
| 과거 주가 | |
|---|---|
| 현재 주가 | US$15.40 |
| 52주 최고가 | US$17.48 |
| 52주 최저가 | US$4.05 |
| 베타 | 1.21 |
| 1개월 변동 | 5.34% |
| 3개월 변동 | 42.46% |
| 1년 변동 | 240.71% |
| 3년 변동 | 100.00% |
| 5년 변동 | n/a |
| IPO 이후 변동 | -48.70% |
최근 뉴스 및 업데이트
FIGS: International Expansion And Q4 Execution Are Expected To Sustain Upside Potential
Analysts have lifted the FIGS fair value estimate from $20.00 to $22.00, reflecting higher modeled revenue growth, a richer future P/E multiple, and Street research that points to momentum following recent earnings and international expansion commentary. Analyst Commentary Recent Street commentary around FIGS has turned more constructive, with several bullish analysts adjusting their price targets higher and revisiting their views after the latest quarterly update.
FIGS: International Expansion And Margin Recovery Efforts Will Drive Upside Potential
Narrative Update on FIGS The updated analyst price target for FIGS reflects a modest recalibration in the model inputs. Recent Street research citing Q4 outperformance, improving profitability and customer trends, and longer term opportunities around international expansion and scaling revenue helps explain why analysts continue to refine their $8 to $20 target range for the stock.FIGS: International Expansion And Margin Recovery Efforts Will Likely Cap Near Term Upside
Narrative Update on FIGS The analyst fair value estimate for FIGS has moved from $9.81 to $16.31 as analysts factor in a series of higher price targets and upgrades that highlight international expansion, margin recovery efforts, and what they describe as sustained recovery and strong momentum following recent Q4 results. Analyst Commentary Recent research on FIGS centers on how the company executes on growth opportunities while working to restore profitability metrics, with price target changes reflecting different views on how quickly that balance can be achieved.Recent updates
FIGS: International Expansion And Q4 Execution Are Expected To Sustain Upside Potential
Analysts have lifted the FIGS fair value estimate from $20.00 to $22.00, reflecting higher modeled revenue growth, a richer future P/E multiple, and Street research that points to momentum following recent earnings and international expansion commentary. Analyst Commentary Recent Street commentary around FIGS has turned more constructive, with several bullish analysts adjusting their price targets higher and revisiting their views after the latest quarterly update.FIGS: International Expansion And Margin Recovery Efforts Will Drive Upside Potential
Narrative Update on FIGS The updated analyst price target for FIGS reflects a modest recalibration in the model inputs. Recent Street research citing Q4 outperformance, improving profitability and customer trends, and longer term opportunities around international expansion and scaling revenue helps explain why analysts continue to refine their $8 to $20 target range for the stock.FIGS: International Expansion And Margin Recovery Efforts Will Likely Cap Near Term Upside
Narrative Update on FIGS The analyst fair value estimate for FIGS has moved from $9.81 to $16.31 as analysts factor in a series of higher price targets and upgrades that highlight international expansion, margin recovery efforts, and what they describe as sustained recovery and strong momentum following recent Q4 results. Analyst Commentary Recent research on FIGS centers on how the company executes on growth opportunities while working to restore profitability metrics, with price target changes reflecting different views on how quickly that balance can be achieved.FIGS: Q4 Execution And Specialty Retail Tailwinds Are Expected To Drive Upside
The analyst fair value estimate for FIGS has increased to $20.00 from $15.00, as analysts point to Q4 earnings strength, improved profitability assumptions, and confidence that the company’s platform can support higher long term revenue potential. Analyst Commentary Recent research on FIGS has turned more constructive, with several bullish analysts revising their fair value views higher after the latest Q4 print and updated outlook.FIGS: Hold On To A Uniquely Positioned Company
Mar 06FIGS: Higher Multiple Assumptions Will Likely Limit Future Share Price Upside
Analysts have nudged their price expectations for FIGS higher, with a modest lift in fair value and future P/E assumptions helping to raise the average price target by about $0.50 as they factor in slightly stronger revenue growth and profit margin potential. Analyst Commentary Recent Street commentary around FIGS points to a mixed but generally constructive stance, with modest price target increases set against ongoing questions about execution and sector risks.
FIGS: Demand Uncertainty In Specialty Retail Will Constrain Future Share Performance
Analysts have raised their FIGS fair value estimate from about $4.00 to roughly $6.20 per share. This reflects updated assumptions for revenue growth, profit margins, and the future P/E multiple that are in line with recent price target increases from firms such as Morgan Stanley, Barclays, and Roth Capital.FIGS: Raised Outlook Will Rely On Specialty Retail Tailwinds Into 2026
Narrative Update Analysts have inched up their price targets on FIGS into the high single digit to low double digit US$ range, citing recent research that points to more constructive views on specialty retail through 2026 and firm specific discussions that suggest ongoing business momentum. At the same time, our model keeps fair value steady at US$15.00, with slightly higher revenue growth, margin and future P/E assumptions.FIGS: Upgraded Outlook Hinges On Strong Brand And Healthcare Apparel Demand
Analysts have lifted their FIGS fair value estimate from US$8.00 to US$15.00, reflecting updated assumptions for revenue growth, profit margins and future P/E, along with a series of recent price target increases from Barclays, Roth Capital, Morgan Stanley, Goldman Sachs and BTIG. Analyst Commentary Recent Street research around FIGS has leaned more constructive, with several bullish analysts lifting price targets and initiating positive coverage.FIGS: Reduced Discounting Will Likely Cap Upside Despite Recent Business Momentum
Analysts have modestly lowered our FIGS fair value estimate to approximately $9.17 per share from about $9.53, even as they raise price targets into the mid single to low double digits. They cite stronger than expected post Q3 momentum, improving demand trends, and a richer future earnings multiple outlook, despite slightly softer long term growth and margin assumptions.FIGS: Recent Momentum Will Likely Fade As Reduced Discounting Limits Upside
Our FIGS fair value estimate increases to $9.53 from $8.78 as analysts lift price targets following stronger than expected Q3 results, sustained business momentum signals, and a more constructive view on the brand's long term earnings power. Analyst Commentary Street research on FIGS has turned more constructive overall, with several firms lifting price targets and initiating positive coverage following the company’s strong Q3 performance and improving demand indicators.FIGS: Share Price Will Likely Reflect Limited Upside Amid Market Caution
Analysts have raised their fair value estimate for FIGS from $7.74 to $8.78, citing stronger than expected business momentum, improved revenue growth expectations, and expanding profit margins. Analyst Commentary Recent research coverage of FIGS has provided a mix of constructive insights and measured caution as analysts adjust their expectations.FIGS: Future Competitive Pressures Will Likely Limit Further Upside
FIGS’ analyst price target has increased from $6.74 to $7.74 per share. Analysts point to stronger revenue growth expectations and positive trends within the healthcare apparel sector, which support the revised outlook.There's Reason For Concern Over FIGS, Inc.'s (NYSE:FIGS) Massive 28% Price Jump
Nov 11
FIGS: High Market Expectations May Limit Upside As Momentum Slows
Analysts have slightly reduced their price target for FIGS, lowering it from $6.74 to $6.74. The adjustment reflects steady business fundamentals and persistent confidence in the brand's strong positioning within the healthcare apparel market.Healthcare, E-Commerce And Global Markets Will Fuel Long-Term Success
Analysts have raised their price target for FIGS from $6.42 to $6.74, citing ongoing strength in U.S. healthcare apparel demand and a solid, debt-free balance sheet as supporting factors for the positive adjustment. Analyst Commentary Recent analyst coverage of FIGS has highlighted both encouraging trends and ongoing areas of caution regarding the company's growth trajectory and valuation.Healthcare, E-Commerce And Global Markets Will Fuel Long-Term Success
The notable upward revision in FIGS' fair value reflects improved consensus revenue growth expectations, more than offsetting the impact of a higher discount rate, resulting in an increased analyst price target from $4.86 to $5.85. What's in the News FIGS, Inc.There's Reason For Concern Over FIGS, Inc.'s (NYSE:FIGS) Massive 35% Price Jump
Jun 30It Looks Like FIGS, Inc.'s (NYSE:FIGS) CEO May Expect Their Salary To Be Put Under The Microscope
May 29Subdued Growth No Barrier To FIGS, Inc. (NYSE:FIGS) With Shares Advancing 40%
May 09Is Now The Time To Look At Buying FIGS, Inc. (NYSE:FIGS)?
May 03FIGS, Inc.: Recommending A Hold Despite Tailwinds
Apr 24FIGS' (NYSE:FIGS) Soft Earnings Don't Show The Whole Picture
Mar 06Figs, Inc. - Slow Growth Is Still Growth
Mar 06Be Wary Of FIGS (NYSE:FIGS) And Its Returns On Capital
Jan 30FIGS: Enter A White Knight?
Dec 12FIGS Back To Q1 Prices, But The Name Is Still A Hold
Nov 13The Price Is Right For FIGS, Inc. (NYSE:FIGS) Even After Diving 26%
Nov 10FIGS (NYSE:FIGS) May Have Issues Allocating Its Capital
Oct 18If EPS Growth Is Important To You, FIGS (NYSE:FIGS) Presents An Opportunity
Oct 03FIGS, Inc.: Growth Potentially Inflecting Upwards
Oct 03At US$5.61, Is FIGS, Inc. (NYSE:FIGS) Worth Looking At Closely?
Sep 18
Tactical Partnerships And Innovations Propel Brand Expansion And Financial Growth
The partnership with Team USA and innovative product lines like Flare ScrubLegging highlight brand visibility enhancement and market expansion efforts.FIGS Q2 2024 Shows Growth At The Expense Of Margins. The Stock Is Still Overpriced
Sep 05FIGS, Inc. (NYSE:FIGS) Shares Could Be 32% Below Their Intrinsic Value Estimate
Aug 06Capital Allocation Trends At FIGS (NYSE:FIGS) Aren't Ideal
Jul 19주주 수익률
| FIGS | US Luxury | US 시장 | |
|---|---|---|---|
| 7D | -6.7% | -2.3% | 0.6% |
| 1Y | 240.7% | 0.4% | 28.7% |
수익률 대 산업: FIGS은 지난 1년 동안 0.4%의 수익을 기록한 US Luxury 산업보다 더 좋은 성과를 냈습니다.
수익률 대 시장: FIGS은 지난 1년 동안 28.7%를 기록한 US 시장보다 더 좋은 성과를 냈습니다.
주가 변동성
| FIGS volatility | |
|---|---|
| FIGS Average Weekly Movement | 10.7% |
| Luxury Industry Average Movement | 7.0% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.2% |
| 10% least volatile stocks in US Market | 3.3% |
안정적인 주가: FIGS는 지난 3개월 동안 US 시장에 비해 주가 변동성이 크지 않았습니다.
시간에 따른 변동성: FIGS의 주간 변동성(11%)은 지난 1년 동안 안정적이었습니다.
회사 소개
| 설립 | 직원 수 | CEO | 웹사이트 |
|---|---|---|---|
| 2013 | 359 | Trina Spear | www.wearfigs.com |
는 자회사인 FIGS Canada, Inc.와 함께 미국 및 전 세계에서 소비자 직접 판매 헬스케어 의류 및 라이프스타일 회사로 운영되고 있습니다. 이 회사는 겉옷, 언더스크럽, 신발, 압박 양말, 실험실 가운, 라운지웨어 및 기타 의류와 같은 수술복 및 비수술복 제품을 디자인하고 판매합니다. 또한 스포츠 의류, 퍼포먼스 레깅스 및 상의, 매우 부드러운 피마면 상의, 조끼, 플리스, 재킷, 그리고 스크럽 캡, 랜야드, 배지 릴, 가방, 야구 모자, 비니 등으로 구성된 필수품도 제공합니다.
FIGS, Inc. 기초 지표 요약
| FIGS 기초 통계 | |
|---|---|
| 시가총액 | US$2.50b |
| 순이익 (TTM) | US$34.25m |
| 매출 (TTM) | US$631.10m |
75.1x
주가수익비율(P/E)4.1x
주가매출비율(P/S)FIGS는 고평가되어 있습니까?
공정 가치 및 평가 분석 보기순이익 및 매출
| FIGS 손익계산서 (TTM) | |
|---|---|
| 매출 | US$631.10m |
| 매출원가 | US$211.26m |
| 총이익 | US$419.84m |
| 기타 비용 | US$385.59m |
| 순이익 | US$34.25m |
최근 보고된 실적
Dec 31, 2025
다음 실적 발표일
May 07, 2026
| 주당순이익(EPS) | 0.21 |
| 총이익률 | 66.53% |
| 순이익률 | 5.43% |
| 부채/자본 비율 | 0% |
FIGS의 장기 실적은 어땠습니까?
과거 실적 및 비교 보기기업 분석 및 재무 데이터 상태
| 데이터 | 최종 업데이트 (UTC 시간) |
|---|---|
| 기업 분석 | 2026/05/01 01:28 |
| 종가 | 2026/05/01 00:00 |
| 수익 | 2025/12/31 |
| 연간 수익 | 2025/12/31 |
데이터 소스
당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.
| 패키지 | 데이터 | 기간 | 미국 소스 예시 * |
|---|---|---|---|
| 기업 재무제표 | 10년 |
| |
| 분석가 컨센서스 추정치 | +3년 |
|
|
| 시장 가격 | 30년 |
| |
| 지분 구조 | 10년 |
| |
| 경영진 | 10년 |
| |
| 주요 개발 | 10년 |
|
* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.
별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.
분석 모델 및 스노우플레이크
이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.
Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.
산업 및 섹터 지표
산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.
분석가 소스
FIGS, Inc.는 14명의 분석가가 다루고 있습니다. 이 중 8명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
| 분석가 | 기관 |
|---|---|
| Adrienne Yih-Tennant | Barclays |
| Robert Drbul | BTIG |
| Brooke Roach | Goldman Sachs |